Clinical Experience with Telavancin for the Treatment of Patients with Bacteremia and Endocarditis: Real-World Results from the Telavancin Observational Use Registry (TOUR™)

BACKGROUND: Bacteremia and endocarditis caused by Staphylococcus aureus (S. aureus), particularly methicillin-resistant S. aureus (MRSA), are challenging to treat and are associated with high morbidity and mortality. Telavancin is a lipoglycopeptide antibacterial active against susceptible Gram-posi...

Descripción completa

Detalles Bibliográficos
Autores principales: Reilly, Joseph, Jacobs, Micah A., Friedman, Bruce, Cleveland, Kerry O., Lombardi, David A., Castaneda-Ruiz, Bibiana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7223833/
https://www.ncbi.nlm.nih.gov/pubmed/32372280
http://dx.doi.org/10.1007/s40801-020-00191-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7223833/
https://www.ncbi.nlm.nih.gov/pubmed/32372280
http://dx.doi.org/10.1007/s40801-020-00191-x

Ejemplares similares